According to recent market research conducted by FMI, the global bioprocess validation market is anticipated to experience robust growth, with a projected CAGR of 9.20% from 2023 to 2033. In 2023, the market size is estimated to reach a valuation of USD 449.03 million, with expectations to surge to approximately USD 996.29 million by 2033. …